|USA: Drug Companies Pushing ADHD Drugs for Children|
by Kelly Hearn, Alternet
November 29th, 2004
As public scrutiny of drug companies grows, so do questions about what critics say is a vast over-prescribing of MPH, especially as more adults are taking other MPH-based medicines such as Concerta. Many in and outside the scientific community suspect the dubious marketing tactics of big drug money have fueled the spiraled use of MPH.
|US: Merck Steps Up Public Relations Campaign After Recall|
by Theresa Agovino, Associated Press
November 22nd, 2004
Merck & Co.'s campaign to defend itself in the wake of the recall of the pain reliever Vioxx intensified as it placed a package of three full-page ads in seven prominent newspapers beginning last Friday.
|US: How Schering Manipulated Drug Prices And Medicaid
New York Times
July 31st, 2004
$345.5 million settlement by Schering-Plough to resolve a government Medicaid investigation provides a detailed glimpse into how drug companies can manipulate prices to overcharge state and federal programs.
|USA: Cynical Politics and the Global HIV/AIDS Emergency|
by Bill Fletcher Jr., FinalCall.com News
August 6th, 2003
National Public Radio (NPR) recently reported on the dramatic increase of HIV/AIDS in the Caribbean. This story reminds one that fighting the spread of HIV/AIDS is directly related to overcoming poverty and challenging globalization. It also reminds one that cynical politics are afoot on the part of those in power more concerned with corporate profits than with the misery of millions.
|USA: Drug Patents Draw Scrutiny as Bush Goes to Africa|
by Michael Schroeder, The Wall Street Journal
July 9th, 2003
In a five-Nation African tour this week, President Bush is trumpeting his $15 billion program to fight the continent's AIDS epidemic. But that program's gains could be undercut by a separate U.S. effort to impose strict drug-patent protections that make AIDS drugs more expensive and harder to obtain. The Commerce Department is helping shape patent laws in developing countries such as Nigeria -- where Mr. Bush will visit Saturday -- that go beyond global standards in protecting drug makers. The U.S. Trade Representative's office is seeking similarly strict protections in developing nations world-wide.
|USA: Bush Delivers Emergency AIDS Relief to Republican Allies|
by John Tarleton, Indy Media Center
July 3rd, 2003
George W. Bush signed a five-year, $15 billion global AIDS relief bill to much fanfare last week in advance of the G8 Summit in Evian, France. Besides giving Bush a PR boost, the measure may turn out to be of more help to U.S. pharmaceutical companies, faith-based religious groups and the biotech industry than to the citizens of 14 African and Caribbean countries covered by the initiative.
|South Africa: Indigenous Group Wins Rights to its Healing Herbs|
by Mercedes Sayagues, Inter Press Service
March 28th, 2003
ANDRIESVALE, South Africa, Mar. 28 (IPS) -- In a victory for indigenous groups, a landmark profit-sharing agreement has been signed providing credit and compensation to one of South Africa's oldest groups with extensive traditional knowledge of healing plants and herbs.
|USA: Pharmaceutical Company Whistle-Blower Tells of 'Illegal' Tactics|
by Liz Kowalczyk, Boston Globe
March 12th, 2003
David Franklin, the drug company whistle-blower who has sparked federal and state investigations into the marketing of the top-selling drug Neurontin, said yesterday that he and his former colleagues engaged in a series of inappropriate tactics, including misleading doctors to persuade them to prescribe the drug for unapproved uses.
|USA: Bush Blocks Cheap Drugs for World's Poor|
by Charlotte Denny, Guardian/UK
February 19th, 2003
George Bush's close links with the drugs industry were last night blamed for the failure of talks in Geneva aimed at securing access to cheap medicines for developing countries.
|Brazil: Hopes Lift at WTO Drugs Talks|
by Bayan Rahman, Financial Times
February 17th, 2003
Brazilian proposal at the weekend has raised hopes of a breakthrough in the World Trade Organisation's deadlocked talks on poor ountries' access to essential medicines.
|USA: Drug Industry Poised to Reap Political Dividends|
by Vicki Kemper, Los Angeles Times
November 8th, 2002
Few industries campaigned harder than pharmaceutical manufacturers to elect Republicans to the new Congress, and few industries are better positioned to reap the rewards of the election returns, analysts said Thursday.
|USA: Feds Pushing Toxic Anthrax Drug?|
by Elliot Borin, Wired.com
October 24th, 2002
Many veterans' advocates believe a certain anthrax vaccine to be a major cause of Gulf War sickness. The company manufacturing it has launched a massive lobbying campaign to persuade the Bush administration to stockpile the controversial drug so it can be administered to civilians.